Triple antiviral drug combo shows promise for treating COVID-19

Credit: Mid-Day- Published on May 10, 2020
A two-week course of antiviral therapy that combines the power of three drugs has shown promise in treating hospitalised patients with mild to moderate COVID-19 in a carefully undertaken phase 2 clinical trial.

The results of the trial, published in the journal The Lancet, involved 127 adults from six public hospitals inย Hong...

You are here

Related videos from verified sources

Texas Department Of State Health Services To Distribute Antiviral Drug Remdesivir In Dallas-Fort Worth To Treat COVID-19 00:37
Credit: CBS Dallas Digital - Published 2 weeks ago 


US allows emergency use of antiviral drug remdesivir to treat Covid-19 patients 02:47
Credit: HT Digital Content - Published on May 2, 2020